The research on cyclophosphamide inhibiting angiogenesis

HU Jing,SUN Xi-tai,QIAN Xiao-ping,LIU Bao-rui,ZOU Zheng-yun,YIN Ming

DOI: https://doi.org/10.3969/j.issn.1672-2353.2005.05.006

2005-01-01

Abstract:Objective To study anti-angiogenetic ability of cyclophosphamide combined with thermotherapy. Methods Human microvascular endothelial cells(HMVEC) were cultured. MTT and number-calculating methods were used to observe cyclophosphamide on HMVEC′s proliferation and sprouts. Results Cyclophosphamide has no influence on endothelial cells at the dose lower than 0.4 mg/mL, but can suppress significantly survival rate of endothelial cells at the dose 0.4～1.6 mg/mL in a dose-dependent manner. No influence on HepGⅡ cells can be observed at the doses from 0.1 mg/mL to 1.6 mg/mL. Conclution Cyclophosphamide can significantly suppress the HMVEC′s prolifetation and sprouts at the dose 0.4～1.6 mg/mL in a dose-dependent manner. The combined use of Cyclophosphamide and thermotherapy has synergistic antiangiogenetic action in vitro.